期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Overall expression of beta-catenin outperforms its nuclear accumulation in predicting outcomes of colorectal cancers 被引量:10
1
作者 Worrawit Wanitsuwan Samornmas Kanngurn +2 位作者 Teeranut Boonpipattanapong Rassamee Sangthong Surasak Sangkhathat 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第39期6052-6059,共8页
AIM: To examine the expression of beta-catenin in colorectal cancer and look for association with other dinico-pathological parameters. METHODS;: Tumor samples from 163 cases of colorectal cancer (CRC) who had und... AIM: To examine the expression of beta-catenin in colorectal cancer and look for association with other dinico-pathological parameters. METHODS;: Tumor samples from 163 cases of colorectal cancer (CRC) who had undergone primary colectomy between May, 1998 and November, 2002 with complete follow-up data for either 5 years or until death were recruited for a beta-catenin immunohistochemical study. The percentage of immunoreacted tumor cells was defined as overall staining density (OSD) and percentage of cells having nuclear localization was counted as nuclear staining density (NSD). Univariate exploration used log-rank test and multivariate survival analysis used Cox's hazard regression model. RESULTS: Beta-catenin immunoreactivity was detected in 161 samples (98.8%), of which 131 cases had nuclear staining. High OSD (≥ 75%), detected in 123 cases (75.5%), was significantly associated with earlier clinical staging (P 〈 0.01), lower nodal status (P = 0.02), non-metastatic status (P 〈 0.01) and better differentiation (P = 0.02). Multivariate analysis found that high OSD was independently associated with better survival [Cox's hazard ratio 0.51, 95% confidence interval (CI) 0.31-0.83]. Although high NSD (≥ 75%) was correlated with high pre-operative serum CEA (P = 0.03), well differentiation (P 〈 0.01), and increased staining intensity(P 〈 0.01), the parameter was not significantly associated with survival. CONCLI3SIOM: Unlike previous reports, the study did not find a predictive value of nuclear beta-catenin in CRC. Instead, the overall expression of beta-catenin in CRC showed an association with better differentiation and earlier staging. Moreover, the parameter also independently predicted superior survival. 展开更多
关键词 Colorectal carcinoma BETA-CATENIN CTNNB1 Wnt-signaling pathway PROGNOSIS
下载PDF
Downregulating activated epidermal growth factor receptor has no effect on RBM5 expression 被引量:1
2
作者 Twinkle J. Masilamani Nina D. Rintala-Maki +1 位作者 WANG Ke Leslie C. Sutherland 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第13期2378-2381,共4页
Background We were interested in determining how the tumor suppressor gene RBM5 is regulated in lung cancers. Previous studies suggested that the gene expression is related to histological subtype and smoking exposure... Background We were interested in determining how the tumor suppressor gene RBM5 is regulated in lung cancers. Previous studies suggested that the gene expression is related to histological subtype and smoking exposure, since in small cell lung cancers the RBM5 gene is deleted whereas in non-small cell lung carcinomas (NSCLC) RBM5 expression is reduced. Of particular interest was the recent finding that in lung adenocarcinomas, a histological subtype of NSCLC, smoking exposure correlated with mutational activity in the transforming growth factor alpha (TGF-c~) signaling pathway. Lung adenocarcinomas from smokers were associated with activating KRAS mutations, whereas lung adenocarcinomas from never-smokers were associated with activating epidermal growth factor receptor (EGFR) mutations. We hypothesized that inhibition of RBM5 in lung adenocarcinomas is achieved indirectly via these activating mutations. The objective of the research described herein was to determine if EGFR activation and RBM5 expression are negatively correlated. Methods EGFR expression in the lung adenocarcinoma cell line NCI-H1975 was inhibited using small interfering RNA. RBM5 expression was examined by real-time quantitative polymerase chain reaction and Western blotting. Results Reduced EGFR expression did not correlate with any change in RBM5 expression at either the RNA or protein level. Conclusion These results suggest that RBM5 expression is not directly regulated by EGFR in non-smoker related lung adenocarinomas, and that some other mechanism operates to inhibit either the expression or function of this potential tumour suppressor in lung cancers that retain the RBM5 gene. 展开更多
关键词 ADENOCARCINOMA epidermal growth factor receptor RBM5 gene expression
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部